Industry Research Reports

Home > Reports > Medical Care > Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Insights, Forecast to 2030

Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Insights, Forecast to 2030

Industry: Medical Care

Published: 2024-12-14

Pages: 131 Pages

Report ld: 3403922

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Cell Therapy
        1.2.3 Cell-derived Products
    1.3 Market by Application
        1.3.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application: 2019 VS 2023 VS 2030
        1.3.2 Large Pharmaceutical Company
        1.3.3 Small and Medium-sized Pharmaceutical Company
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Perspective (2019-2030)
    2.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Trends by Region
        2.2.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Region (2019-2024)
        2.2.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Region (2025-2030)
    2.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Dynamics
        2.3.1 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Trends
        2.3.2 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
        2.3.3 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Challenges
        2.3.4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service by Players
        3.1.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Players (2019-2024)
        3.1.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Players (2019-2024)
    3.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Concentration Ratio
        3.4.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue in 2023
    3.5 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Head office and Area Served
    3.6 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Product and Application
    3.7 Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Breakdown Data by Type
    4.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Type (2019-2024)
    4.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Type (2025-2030)

 5 Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Breakdown Data by Application
    5.1 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Historic Market Size by Application (2019-2024)
    5.2 Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    6.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type
        6.2.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
        6.2.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
        6.2.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
    6.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application
        6.3.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
        6.3.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
        6.3.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
    6.4 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        6.4.1 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
        6.4.3 North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

 7 Europe
    7.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    7.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type
        7.2.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
        7.2.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
        7.2.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
    7.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application
        7.3.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
        7.3.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
        7.3.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
    7.4 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        7.4.1 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
        7.4.3 Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
        7.4.4 Germany
        7.4.5 France
        7.4.6 U.K.
        7.4.7 Italy
        7.4.8 Russia
        7.4.9 Nordic Countries

 8 China
    8.1 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    8.2 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type
        8.2.1 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
        8.2.2 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
        8.2.3 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
    8.3 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application
        8.3.1 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
        8.3.2 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
        8.3.3 China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    9.2 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type
        9.2.1 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
        9.2.2 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
        9.2.3 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
    9.3 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application
        9.3.1 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
        9.3.2 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
        9.3.3 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
    9.4 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region
        9.4.1 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024)
        9.4.3 Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Lonza
        11.1.1 Lonza Company Details
        11.1.2 Lonza Business Overview
        11.1.3 Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.1.4 Lonza Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.1.5 Lonza Recent Development
    11.2 uBriGene Biosciences International
        11.2.1 uBriGene Biosciences International Company Details
        11.2.2 uBriGene Biosciences International Business Overview
        11.2.3 uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.2.4 uBriGene Biosciences International Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.2.5 uBriGene Biosciences International Recent Development
    11.3 Thermo Fisher
        11.3.1 Thermo Fisher Company Details
        11.3.2 Thermo Fisher Business Overview
        11.3.3 Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.3.4 Thermo Fisher Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.3.5 Thermo Fisher Recent Development
    11.4 Creative Biolabs
        11.4.1 Creative Biolabs Company Details
        11.4.2 Creative Biolabs Business Overview
        11.4.3 Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.4.4 Creative Biolabs Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.4.5 Creative Biolabs Recent Development
    11.5 REPROCELL
        11.5.1 REPROCELL Company Details
        11.5.2 REPROCELL Business Overview
        11.5.3 REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.5.4 REPROCELL Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.5.5 REPROCELL Recent Development
    11.6 ATCC
        11.6.1 ATCC Company Details
        11.6.2 ATCC Business Overview
        11.6.3 ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.6.4 ATCC Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.6.5 ATCC Recent Development
    11.7 Beijing CytoNiche Biotech
        11.7.1 Beijing CytoNiche Biotech Company Details
        11.7.2 Beijing CytoNiche Biotech Business Overview
        11.7.3 Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.7.4 Beijing CytoNiche Biotech Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.7.5 Beijing CytoNiche Biotech Recent Development
    11.8 OmniaBio
        11.8.1 OmniaBio Company Details
        11.8.2 OmniaBio Business Overview
        11.8.3 OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.8.4 OmniaBio Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.8.5 OmniaBio Recent Development
    11.9 Histocell
        11.9.1 Histocell Company Details
        11.9.2 Histocell Business Overview
        11.9.3 Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.9.4 Histocell Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.9.5 Histocell Recent Development
    11.10 FUJIFILM Diosynth Biotechnologies
        11.10.1 FUJIFILM Diosynth Biotechnologies Company Details
        11.10.2 FUJIFILM Diosynth Biotechnologies Business Overview
        11.10.3 FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.10.4 FUJIFILM Diosynth Biotechnologies Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.10.5 FUJIFILM Diosynth Biotechnologies Recent Development
    11.11 Taiwan Bio Therapeutics
        11.11.1 Taiwan Bio Therapeutics Company Details
        11.11.2 Taiwan Bio Therapeutics Business Overview
        11.11.3 Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.11.4 Taiwan Bio Therapeutics Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.11.5 Taiwan Bio Therapeutics Recent Development
    11.12 Encell Co., Ltd.
        11.12.1 Encell Co., Ltd. Company Details
        11.12.2 Encell Co., Ltd. Business Overview
        11.12.3 Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.12.4 Encell Co., Ltd. Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.12.5 Encell Co., Ltd. Recent Development
    11.13 Mycenax
        11.13.1 Mycenax Company Details
        11.13.2 Mycenax Business Overview
        11.13.3 Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Introduction
        11.13.4 Mycenax Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
        11.13.5 Mycenax Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Cell Therapy
 Table 3. Key Players of Cell-derived Products
 Table 4. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2019-2024)
 Table 8. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2025-2030)
 Table 10. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Trends
 Table 11. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Drivers
 Table 12. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Challenges
 Table 13. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Restraints
 Table 14. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Players (2019-2024)
 Table 16. Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service as of 2023)
 Table 17. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Headquarters and Area Served
 Table 20. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Product and Application
 Table 21. Global Key Players of Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Type (2019-2024)
 Table 25. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Type (2025-2030)
 Table 27. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Application (2019-2024)
 Table 29. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue Market Share by Application (2025-2030)
 Table 31. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Lonza Company Details
 Table 64. Lonza Business Overview
 Table 65. Lonza Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 66. Lonza Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 67. Lonza Recent Development
 Table 68. uBriGene Biosciences International Company Details
 Table 69. uBriGene Biosciences International Business Overview
 Table 70. uBriGene Biosciences International Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 71. uBriGene Biosciences International Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 72. uBriGene Biosciences International Recent Development
 Table 73. Thermo Fisher Company Details
 Table 74. Thermo Fisher Business Overview
 Table 75. Thermo Fisher Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 76. Thermo Fisher Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 77. Thermo Fisher Recent Development
 Table 78. Creative Biolabs Company Details
 Table 79. Creative Biolabs Business Overview
 Table 80. Creative Biolabs Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 81. Creative Biolabs Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 82. Creative Biolabs Recent Development
 Table 83. REPROCELL Company Details
 Table 84. REPROCELL Business Overview
 Table 85. REPROCELL Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 86. REPROCELL Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 87. REPROCELL Recent Development
 Table 88. ATCC Company Details
 Table 89. ATCC Business Overview
 Table 90. ATCC Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 91. ATCC Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 92. ATCC Recent Development
 Table 93. Beijing CytoNiche Biotech Company Details
 Table 94. Beijing CytoNiche Biotech Business Overview
 Table 95. Beijing CytoNiche Biotech Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 96. Beijing CytoNiche Biotech Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 97. Beijing CytoNiche Biotech Recent Development
 Table 98. OmniaBio Company Details
 Table 99. OmniaBio Business Overview
 Table 100. OmniaBio Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 101. OmniaBio Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 102. OmniaBio Recent Development
 Table 103. Histocell Company Details
 Table 104. Histocell Business Overview
 Table 105. Histocell Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 106. Histocell Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 107. Histocell Recent Development
 Table 108. FUJIFILM Diosynth Biotechnologies Company Details
 Table 109. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 110. FUJIFILM Diosynth Biotechnologies Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 111. FUJIFILM Diosynth Biotechnologies Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 112. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 113. Taiwan Bio Therapeutics Company Details
 Table 114. Taiwan Bio Therapeutics Business Overview
 Table 115. Taiwan Bio Therapeutics Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 116. Taiwan Bio Therapeutics Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 117. Taiwan Bio Therapeutics Recent Development
 Table 118. Encell Co., Ltd. Company Details
 Table 119. Encell Co., Ltd. Business Overview
 Table 120. Encell Co., Ltd. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 121. Encell Co., Ltd. Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 122. Encell Co., Ltd. Recent Development
 Table 123. Mycenax Company Details
 Table 124. Mycenax Business Overview
 Table 125. Mycenax Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Product
 Table 126. Mycenax Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024) & (US$ Million)
 Table 127. Mycenax Recent Development
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type: 2023 VS 2030
 Figure 3. Cell Therapy Features
 Figure 4. Cell-derived Products Features
 Figure 5. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application: 2023 VS 2030
 Figure 7. Large Pharmaceutical Company Case Studies
 Figure 8. Small and Medium-sized Pharmaceutical Company Case Studies
 Figure 9. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Report Years Considered
 Figure 10. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 11. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region: 2023 VS 2030
 Figure 13. Global Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Players in 2023
 Figure 14. Global Top Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service as of 2023)
 Figure 15. The Top 10 and 5 Players Market Share by Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Revenue in 2023
 Figure 16. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 17. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
 Figure 18. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
 Figure 19. North America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 20. United States Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
 Figure 24. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
 Figure 25. Europe Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 26. Germany Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
 Figure 34. China Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
 Figure 35. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
 Figure 37. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
 Figure 38. Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Region (2019-2030)
 Figure 39. Japan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. South Korea Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Type (2019-2030)
 Figure 47. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Application (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Share by Country (2019-2030)
 Figure 49. Brazil Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Mexico Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Turkey Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Israel Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. GCC Countries Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Lonza Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 56. uBriGene Biosciences International Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 57. Thermo Fisher Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 58. Creative Biolabs Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 59. REPROCELL Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 60. ATCC Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 61. Beijing CytoNiche Biotech Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 62. OmniaBio Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 63. Histocell Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 64. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 65. Taiwan Bio Therapeutics Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 66. Encell Co., Ltd. Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 67. Mycenax Revenue Growth Rate in Mesenchymal Stem Cell (MSCs) Therapeutic Product CDMO Service Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed

Mesenchymal stem cell (MSCs) therapeutic product CDMO (Contract Development and Manufacturing Organization) services refer to a series of services from research and development to production for mesenchymal stem cell-related therapeutic products. CDMOs usually provide outsourcing services to pharmaceutical and biotechnology companies to help them develop and produce biologics in the preclinical and clinical stages.